A growing biomanufacturing sector at Genopole
The bioeconomy is a major axis for Genopole. The sector is growing on a foundation of progress in sequencing technologies, advances in synthetic biology and the promising possibilities of certain innovations on several markets. Thirty biocluster companies are active in this sector rich in disruptive innovations empowering both the industrial future of France and the environmental protection of the planet. Also, the academic actors Genoscope (CEA) and its Genomics Metabolics mixed research unit contribute to the sector’s growth via the sequencing of numerous plant species and the analysis of bacterial genomes, all sources for novel functions.
Research and R&D at Genopole explore many facets of the bioeconomy, in fields such as envirotech (biodetection of pollutants), agritech (responsible agricultural practices, alternative proteins, etc.) and industrial biotechnologies (biofuels, ingredients, materials, aromas, cosmetics, etc.).
Genopole was France’s pioneer site for synthetic biology, which continues to be highly present at the biocluster. The field directs lab-cultured microorganisms toward the production of compounds of interest for industry. Today’s objective is the pre-industrial deployment of the specialty. Thereto, Genopole launched a "biofoundry"-style integrative platform project for synthetic biology in 2021. Also to support its position, Genopole sponsored the March 2021 Bioket event, which was focused notably on innovative biomass pretreatment, process modeling and advanced fermentation. There, Genopole provided a plenary presentation entitled "Synthetic biology, a multi-stage rocket for the bioeconomy?".
Year 2021 also saw the conceptualization of a foodlab, named Protopia, that will take the form of a shared-use laboratory with the equipment necessary for research on new foods and protein alternatives. Genopole’s objectives with this initiative are to respond to the needs of its growing number of accompanied start-ups and to attract new businesses with a structure currently unique in Île-de-France. In this manner, Genopole intends to consolidate its bioeconomy strategic sector. Indeed, this latter is an increasingly dynamic entrepreneurial space in sync with the expectations of society and industry, and an object of growing attention from investors.